PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia

Albert Einstein College of Medicine becomes the First Limited Collaborator in Break Through Cancer’s AML Research Initiative

Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia
2024-11-12
(Press-News.org) November 12, 2024—(BRONX, NY)— Marina Konopleva, M.D., Ph.D., director of the Leukemia Program and co-director of the Blood Cancer Institute at the National Cancer Institute-designated Montefiore Einstein Comprehensive Cancer Center (MECCC), has joined forces with Break Through Cancer, a collaborative medical research foundation that supports teams of scientists as they advance treatments for some of the world’s deadliest cancers. Dr. Konopleva will play a pivotal role in the Eradicating Minimal Residual Disease (MRD) in Acute Myelogenous Leukemia (AML) TeamLab.

Dr. Konopleva’s participation in the TeamLab also marks Albert Einstein College of Medicine becoming one of the first limited collaborators with Break Through Cancer, a strategic extension of Break Through Cancer’s effort to harness specialized expertise from top cancer centers nationwide.

“Dr. Konopleva’s exceptional track record in pioneering targeted therapies for AML makes her an invaluable addition to our team,” said Tyler Jacks, Ph.D., president, Break Through Cancer; founding director, MIT’s Koch Institute for Integrative Cancer Research; David H. Koch Professor of Biology. “Her work is crucial as we aim to eradicate MRD in AML, which is often responsible for relapse in patients.”

A Collaborative Model for a Complicated Disease
AML presents a pressing issue in blood cancer care. While patients often respond well to initial treatment, most quickly relapse, resulting in a five-year survival rate of 30%. Relapse is believed to be triggered by MRD, when surviving cancer cells seed new disease that is resistant to existing therapies.

Dr. Konopleva, a physician-scientist at MECCC and professor of oncology and of molecular pharmacology and the Miriam Mandel Faculty Scholar in Cancer Research at Albert Einstein College of Medicine, has brought multiple targeted agents from pre-clinical investigations into clinical trials for blood cancers like AML, most notably BCL-2 inhibitor Venetoclax which in combination with low-intensity therapies has become a standard of care for older AML patients unfit for intensive chemotherapy.

“MECCC has long embraced a collaborative model for cancer research, which has become even more necessary as the complexity of the science increases,” said Edward Chu, M.D., M.M.S., director of MECCC and interim chair of oncology at Einstein and Montefiore Health System. “Break Through Cancer’s approach—which significantly mitigates the administrative issues that can hobble teamwork among researchers at different institutions—is extraordinary. We are proud to join this effort focused on rapidly translating science for the benefit of patients.” Dr. Chu is also the Carol and Roger Einiger Professor of Cancer Medicine and professor of oncology, of medicine, and of molecular pharmacology at Einstein, and vice-president of cancer medicine at Montefiore Medicine.

Break Through Cancer’s Eradicating MRD in AML team is currently comprised of two dozen researchers from six top cancer centers around the country, investigating how these cells effectively evade chemotherapy and the immune system and is developing new ways to detect and target MRD.

“MECCC has been a leader in developing new protocols for patients with AML, advancing treatments and ensuring they are more tolerable and less toxic to patients,” said Dr. Konopleva. “By partnering with BTC and building on our collective successes, we will deepen our understanding of the drivers of MRD and expand the potential for creative approaches that can evolve the treatment landscape.”

***

About Montefiore Einstein Comprehensive Cancer Center 
Montefiore Einstein Comprehensive Cancer Center (MECCC) is a National Cancer Institute (NCI)-designated comprehensive cancer center and a national leader in cancer research and care located in the racially and ethnically diverse borough of the Bronx, N.Y. MECCC combines the exceptional science of Albert Einstein College of Medicine with the multidisciplinary and team-based approach to cancer clinical care at Montefiore Health System. Founded in 1971 and a NCI-designated cancer center since 1972, MECCC is redefining excellence in cancer research, clinical care, education and training, and community outreach and engagement. Its mission is to reduce the burden of cancer for all, especially people from historically underrepresented groups. 

END


[Attachments] See images for this press release:
Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia 2

ELSE PRESS RELEASES FROM THIS DATE:

Early treatment for nerve tumors prevents serious problems, study finds

Early treatment for nerve tumors prevents serious problems, study finds
2024-11-12
Patients with a small cranial nerve tumor that can cause hearing loss, vertigo, imbalance and ringing in the ears have typically been watched rather than proactively treated, as the risks of early intervention were thought to outweigh the benefits. However, even those patients benefit significantly from non-invasive stereotactic radiosurgery, a multicenter, international study led by UVA Health physicians has found. Doctors typically treat larger forms of the tumors, called vestibular schwannomas, while taking a “watch and wait” approach ...

Study: Student absenteeism crisis may be hurting teacher job satisfaction

2024-11-12
Washington, November 12, 2024—As student absenteeism reaches record highs in schools across the United States, new research finds that student absences are linked to lower teacher job satisfaction, raising concerns that this may exacerbate growing teacher shortages. The findings were published today in Educational Researcher, a peer-reviewed journal of the American Educational Research Association. The study, by Michael Gottfried and Colby Woods at the University of Pennsylvania, and Arya Ansari at The Ohio State University, is the first ...

Medicaid enrollment continuity tied to lymphoma stage at diagnosis

2024-11-12
(WASHINGTON, November 12, 2024) – Continuous enrollment in Medicaid was associated with a lower rate of a late-stage lymphoma diagnosis in children and adolescents/young adults (AYAs). However, fewer than half of Medicaid-insured patients in these age ranges were continuously enrolled before diagnosis, according to a study published today in Blood Advances. Lymphoma – which is divided into two types, Hodgkin lymphoma (HL) and non-Hodgkin lymphoma (NHL) – is a cancer of the lymphatic system and ...

INSEAD launches free Negotiation Course for the World

INSEAD launches free Negotiation Course for the World
2024-11-12
If knowledge is power, empowering the world with the art and science of negotiation offers even more far-reaching benefits – a more peaceful and prosperous world, according to the INSEAD Negotiation and Conflict Management Collaborative (NCMC). The Negotiation Course for the World (NCW) is a pioneering effort by the NCMC to make quality negotiation teaching materials and expertise accessible to all, and in so doing, democratise negotiation education. “It is an integral part of the NCMC’s mandate to bring scholars and practitioners together to collaborate on research and education on negotiation and conflict management,” said Roderick Swaab, Professor ...

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer

Wyss Institute’s iNodes team receives ARPA-H Sprint for Women’s Health award to advance the first implantable immune organs to treat ovarian cancer
2024-11-12
By Benjamin Boettner   (BOSTON) — Ovarian cancer is more deadly than any other type of female reproductive organ cancer. It is estimated that in 2024, in the U.S. alone, more than 12,000 women will die from the disease because available therapies are not effective. To help overcome this striking deficit in women’s health, ARPA-H has selected a team at the Wyss Institute at Harvard University as an awardee of its Sprint for Women’s Health effort to develop “iNodes” – implantable lymphoid organs containing patients’ immune cells – as an entirely novel form of personalized immunotherapy to treat ovarian ...

Goblet cells could be the guardians of the gut

Goblet cells could be the guardians of the gut
2024-11-12
In a recent study, researchers at the University of California, San Diego, have provided new insights into the central role of goblet cells—specialized cells that line the gut—in maintaining a healthy and balanced immune environment within the gastrointestinal (GI) tract. Led by Dr Fernanda Raya Tonetti, with Dr. Cristina Llorente directing the project and making significant contributions, the study underscores the critical roles of these cells, which act not only as a physical barrier but also ...

Romania’s science journalists join forces on new reporting handbook 

Romania’s science journalists join forces on new reporting handbook 
2024-11-12
The Balkan Network of Science Journalists and the European Federation for Science Journalism are launching a new science journalism guide, this time in Romanian.  From the Field: A Science Journalist's Handbook is the result of a collective effort by more than 20 Romanian journalists and content creators who dedicated their time and expertise to build a 138-page document designed to help journalists navigate the complex world of science reporting. The guide was coordinated by science ...

SwRI-led team proposes new solar composition ratios that could reconcile longstanding questions

SwRI-led team proposes new solar composition ratios that could reconcile longstanding questions
2024-11-12
SAN ANTONIO — November 12, 2024 — A Southwest Research Institute-led team combined compositional data of primitive bodies like Kuiper Belt objects, asteroids and comets with new solar data sets to develop a revised solar composition that potentially reconciles spectroscopy and helioseismology measurements for the first time. Helioseismology probes the Sun’s interior by analyzing the waves that travel through it, while spectroscopy reveals the surface composition based on the spectral signature produced by each chemical element.   A paper about this research, which ...

Sodium butyrate inhibits necroptosis by regulating MLKL via E2F1 in intestinal epithelial cells of liver cirrhosis

Sodium butyrate inhibits necroptosis by regulating MLKL via E2F1 in intestinal epithelial cells of liver cirrhosis
2024-11-12
Background and Aims Necroptosis is critical for regulating intestinal epithelial cells (IECs). Butyric acid (BA), produced during intestinal microbial metabolism, protects the intestinal epithelial barrier. However, whether necroptosis occurs in IECs during liver cirrhosis and whether sodium butyrate (NaB) can regulate necroptosis have not yet been reported. In this study, we aimed to investigate whether IECs undergo necroptosis in cirrhosis and whether NaB can regulate necroptosis and the related regulatory mechanisms. Methods Serum levels of RIPK3, MLKL, and Zonulin, as well as fecal BA levels, were measured and correlated in 48 patients with liver cirrhosis ...

In greening Arctic, caribou and muskoxen play key role

In greening Arctic, caribou and muskoxen play key role
2024-11-12
The story of Arctic greening has overlooked some main characters. At center stage are climate change and warming temperatures. Meanwhile, large grazing wildlife, such as caribou and muskoxen, also play a key role in the timing and abundance of Arctic plants, according to a study from the University of California, Davis. The study, published today in the journal PNAS Nexus, highlights the importance of large herbivores to the Arctic ecosystem, linking grazing with plant phenology and abundance in the Arctic tundra. Phenology is the study of the timing and cyclical patterns in nature, such as when birds migrate, or when a plant first sprouts or blooms. ...

LAST 30 PRESS RELEASES:

UTokyo and NARO develop new vertical seed distribution trait for soybean breeding

Research into UK’s use of plastic packaging finds households ‘wishcycle’ rather than recycle – risking vast contamination

Vaccine shows promise against aggressive breast cancer

Adverse events affect over 1 in 3 surgery patients, US study finds

Outsourcing adult social care has contributed to England’s care crisis, argue experts

The Lancet: Over 800 million adults living with diabetes, more than half not receiving treatment, global study suggests

New therapeutic approach for severe COVID-19: faster recovery and reduction in mortality

Plugged wells and reduced injection lower induced earthquake rates in Oklahoma

Yin selected as a 2024 American Society of Agronomy Fellow

Long Covid could cost the economy billions every year

Bluetooth technology unlocks urban animal secrets

This nifty AI tool helps neurosurgeons find sneaky cancer cells

Treatment advances, predictive biomarkers stand to improve bladder cancer care

NYC's ride-hailing fee failed to ease Manhattan traffic, new NYU Tandon study reveals

Meteorite contains evidence of liquid water on Mars 742 million years ago

Self-reported screening helped reduce distressing symptoms for pediatric patients with cancer

Which risk factors are linked to having a severe stroke?

Opening borders for workers: Abe’s profound influence on Japan’s immigration regime

How skills from hospitality and tourism can propel careers beyond the industry

Research shows managers of firms handling recalls should review media scrutiny before deciding whether to lobby

New model system for the development of potential active substances used in condensate modifying drugs

How to reduce social media stress by leaning in instead of logging off

Pioneering research shows sea life will struggle to survive future global warming

In 10 seconds, an AI model detects cancerous brain tumor often missed during surgery 

Burden of RSV–associated hospitalizations in US adults, October 2016 to September 2023

Repurposing semaglutide and liraglutide for alcohol use disorder

IPK-led research team provides insights into the pangenome of barley

New route to fluorochemicals: fluorspar activated in water under mild conditions

Microbial load can influence disease associations

Three galactic “red monsters” in the early Universe

[Press-News.org] Montefiore Einstein’s Marina Konopleva joins Break Through Cancer TeamLab in fight against acute myelogenous leukemia
Albert Einstein College of Medicine becomes the First Limited Collaborator in Break Through Cancer’s AML Research Initiative